Andres Abin-Fuentes, Ph.D.

Andres Abin-Fuentes, Ph.D., is a Senior Director, Biopharmaceutical Development, Deerfield Discovery and Development and joined the Firm in 2024. Prior to Deerfield, Dr. Abin-Fuentes was a Director, Biologics & Gene Therapy Process Development & Manufacturing for Cartesian Therapeutics (and formerly Selecta Biosciences) for three years. Before Cartesian, he was with Synlogic, Inc., for three years, most recently as Head of Bioprocess Development.  Dr. Abin-Fuentes has also held roles with Vertex Pharmaceuticals, Inc., Goodwin Biotechnology, Inc., Bristol-Myers Squibb.  Dr. Abin-Fuentes holds a B.S. in Chemical Engineering from the University of Minnesota-Twin Cities, an M.Sc. in Chemical Engineering and a Ph.D. in Chemical Engineering Practices from the Massachusetts Institute of Technology, an M.B.A. from the University of Nebraska, and an M.S. in Data Science from Eastern University.